This message was sent to ##Email##
|
| June 22, 2016 |
| |  | | |
|
|
|
| |
ScienceDaily
The results of a study found a doubled risk of pre-malignant cervical changes, and potentially also an increased risk of cervical cancer, among women with Systemic Lupus Erythematosus (SLE) compared to the general female population. The highest risks were found in women with SLE who were treated with immunosuppressant drugs. These findings highlight the importance of regular cervical screening in all women with SLE, regardless of whether the increased risk is due to disease severity or treatment.
READ MORE
ASCT
ASCT members have access to a wealth of knowledge and resources. Check the "Ask ASCT" directory of 16 topics and 19 contact people. Topics include CAP Inspection, Competency Assessment, Lab Design, Test Validation and Personnel Management. You can email your questions directly from the ASCT website. Visit the Member’s Only Section to access "Ask ASCT."
| Date |
Event |
Location |
More information |
July 14, 2016
|
Unlocking Horns: Solutions
For Managing Conflict |
Your PC |
 Barbara A. Crothers,
D.O.
NCC Pathology
Program Director
Walter Reed National
Military
Medical
Center
Bethesda, Maryland
|
More info |
Register
|
Available for 6 months after subscribing |
Quality Assessment Center (QAC) Cell Blocks Basics Workbench
|
Your PC |
Details |
Available for 6 months after subscribing |
Quality Assessment Center (QAC)
Document Control for Cytopathology Workbench
|
Your PC |
Details |
Available for 6 months after subscribing |
Quality Assessment Center (QAC)
The LEAN Cytopathology Laboratory Workbench
|
Your PC |
Details |
 |
|
The Cyto-Tek® 2500 offers excellent
preservation of cellular structure and consistently delivers a high rate of
cellular recovery. With its patented paced acceleration feature, the instrument
automatically increases and decreases the rotational velocity based on the selected
speed, which protects fragile cells and results in higher cellular yield.
|
|
Cancer Network
Testing for human papillomavirus infections in urine could be an extremely accurate way to exclude the possibility of such infections and screen for cervical cancer, according to a new study. The urinary testing includes HPV types not included in vaccines.
High-risk HPV infections are the most important risk factor for developing cervical cancer as well as the cancer precursor lesions known as cervical intraepithelial neoplasias.
READ MORE
Healio
A recently published literature review suggested that global uptake of Gardasil quadrivalent HPV vaccine has led to a major reduction in infection rates, as well as fewer reports of several related conditions. HPV incidence declined nearly 90 percent in regions with higher population coverage, but lagged among those with lower uptake, according to Suzanne M. Garland, MBBS, MD, director of the women’s center for infectious diseases at the University of Melbourne’s Royal Women’s Hospital, and colleagues. They said this highlights the need for increased vaccination coverage among lower income countries and difficult-to-reach populations.
READ MORE
Medscape
The development of human papillomavirus vaccines, which prevent a range of HPV-related cancers, is a truly impressive scientific achievement. In the decade since approval of the quadrivalent vaccine for the prevention of HPV types 6, 11, 16, and 18, the vaccine has been shown to be highly effective. Recently, a nine-valent vaccine was approved, which protects against five additional oncogenic HPV types, providing increased protection.
READ MORE
Cancer Network
Pembrolizumab is well-tolerated and shows promising antitumor activity and early survival rates among patients with PD-L1–positive cervical squamous cell cancer, according to preliminary results from the phase Ib KEYNOTE-028 trial, presented at the 2016 American Society of Clinical Oncology (ASCO) Annual Meeting.
READ MORE
Fusion
There aren't many things that you can say a quarter of the U.S. population has in common, but HPV (human papillomavirus) is apparently one of them. Approximately 79 million Americans currently have HPV. It's the most common STI in the country. In fact, the vast majority of sexually active adults will contract it eventually.
The curious thing about HPV, which is as yet incurable, is how differently it impacts men and women.
READ MORE
AAP News
Improving access to human papillomavirus vaccine leads to more improvement in vaccine uptake than other interventions, according to a new study.
Such interventions often come in the form of school-based vaccination programs that reach large number of adolescents.
READ MORE
Reuters
Barriers to getting tested or treated for sexually transmitted disease need to be lowered, a U.S. study concludes.
In 2013, before the Affordable Care Act — better known as Obamacare — was fully implemented, researchers found that half of patients at STD clinics were unwilling to use their health insurance for their visits, mainly because they worried about privacy or cost.
READ MORE
By Dorothy L. Tengler
 Methicillin-resistant Staphylococcus aureus infection — better known as MRSA — is caused by a type of staph bacteria that has become resistant to many of the antibiotics used to treat ordinary staph infections. Thus, treating this potentially deadly infection has been a challenge for healthcare professionals. But a new experimental antibiotic developed by a team of scientists at Rutgers University has successfully treated MRSA in animal models.
READ MORE
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
